ZA957139B - Compositions which are suitable for employment as antidotes to blood anticoagulants and their use - Google Patents

Compositions which are suitable for employment as antidotes to blood anticoagulants and their use

Info

Publication number
ZA957139B
ZA957139B ZA957139A ZA957139A ZA957139B ZA 957139 B ZA957139 B ZA 957139B ZA 957139 A ZA957139 A ZA 957139A ZA 957139 A ZA957139 A ZA 957139A ZA 957139 B ZA957139 B ZA 957139B
Authority
ZA
South Africa
Prior art keywords
antidotes
employment
compositions
blood anticoagulants
anticoagulants
Prior art date
Application number
ZA957139A
Other languages
English (en)
Inventor
Juergen Roemisch
Karl-Heinz Diehl
Hans-Arnold Stoehr
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of ZA957139B publication Critical patent/ZA957139B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/366—Thrombomodulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA957139A 1994-08-26 1995-08-25 Compositions which are suitable for employment as antidotes to blood anticoagulants and their use ZA957139B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4430205A DE4430205A1 (de) 1994-08-26 1994-08-26 Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung

Publications (1)

Publication Number Publication Date
ZA957139B true ZA957139B (en) 1996-03-26

Family

ID=6526564

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA957139A ZA957139B (en) 1994-08-26 1995-08-25 Compositions which are suitable for employment as antidotes to blood anticoagulants and their use

Country Status (8)

Country Link
EP (1) EP0700684A3 (fr)
JP (1) JP3859176B2 (fr)
KR (1) KR960006938A (fr)
AU (1) AU3025795A (fr)
CA (1) CA2156991A1 (fr)
DE (1) DE4430205A1 (fr)
IL (1) IL115058A0 (fr)
ZA (1) ZA957139B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4437544A1 (de) * 1994-10-20 1996-04-25 Behringwerke Ag Einsatz von vWF-enthaltenden Konzentraten als Kombinationstherapie bei Therapie mit Antithrombotika und Fibrinolytika
HUP9700603A3 (en) * 1996-03-20 2001-08-28 Baxter Ag Pharmaceutical preparation for the treatment of blood coagulation disorders
AT404673B (de) * 1996-03-20 1999-01-25 Immuno Ag Pharmazeutisches präparat zur behandlung von blutgerinnungsstörungen
DE19710190A1 (de) * 1997-03-12 1998-09-17 Immuno Ag Aktivierter Vitamin K-abhängiger Blutfaktor und Verfahren zu dessen Herstellung
AT409334B (de) * 1997-09-19 2002-07-25 Immuno Ag Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren
AT407484B (de) 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
JPWO2003099324A1 (ja) * 2002-05-23 2005-09-22 中外製薬株式会社 組織因子阻害剤中和剤及び活性型血液凝固第ｖｉｉ因子製剤中和剤
DK1528930T3 (da) * 2002-07-23 2009-08-03 Bio & Bio Licensing Sa Thrombindannelsesdygtige og thrombinholdige farmaceutiske præparater af virksomt stof samt lægemidler
EP1523327A1 (fr) 2002-07-23 2005-04-20 Bio-Products & Bio-Engineering Aktiengesellschaft Preparations de principes actifs pharmaceutiques et medicaments generant ou contenant de la thrombine
EP1935429A1 (fr) 2006-12-22 2008-06-25 CSL Behring GmbH Utilisation thérapeutique synergique de concentrés de complexe prothrombinique avec des concentrés de FVIII
US8268783B2 (en) 2007-09-28 2012-09-18 Portola Pharmaceuticals, Inc. Antidotes for factor Xa inhibitors and methods of using the same
SG185263A1 (en) 2007-09-28 2012-11-29 Portola Pharm Inc Antidotes for factor xa inhibitors and methods of using the same
DE102008032361A1 (de) 2008-07-10 2010-01-21 Csl Behring Gmbh Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie
US8455439B2 (en) * 2008-11-14 2013-06-04 Portola Pharmaceuticals, Inc. Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agents
US20140128732A1 (en) 2012-11-06 2014-05-08 Cross Bay Medical, Inc. Biopsy and sonography method and apparatus for assessing bodily cavities
FR3000895B1 (fr) 2013-01-11 2017-02-24 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Sa Utilisation d'antidotes d'inhibiteurs de la coagulation indiques dans la prevention ou le traitement de pathologies thromboemboliques
ES2657291T3 (es) 2013-04-22 2018-03-02 Csl Ltd. Un complejo covalente de factor de von Willebrand y factor VIII asociado por un puente disulfuro
EP3175245B1 (fr) * 2014-07-31 2019-05-29 Haemonetics Corporation Détection et classification d'un anticoagulant à l'aide d'un test de coagulation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE443293B (sv) * 1978-01-25 1986-02-24 Blombaeck E G B Blodfraktionsframstellning
WO1981002105A1 (fr) * 1980-01-28 1981-08-06 Baxter Travenol Lab Compositions therapeutiques et procede de fabrication et d'utilisation de celles-ci
US4386068A (en) * 1980-02-26 1983-05-31 Cutter Laboratories, Inc. Antihemophilic factor concentrate and method for preparation
AU3098289A (en) 1988-03-04 1989-09-07 Biogen, Inc. Hirudin peptides
GB8823480D0 (en) * 1988-10-06 1988-11-16 Ciba Geigy Ag Antidote
US5240913A (en) 1989-08-18 1993-08-31 Biogen, Inc. Inhibitors of thrombin
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.
DE4203965A1 (de) * 1992-02-11 1993-08-12 Max Planck Gesellschaft Antidot fuer hirudin und synthetische thrombininhibitoren
CA2148817A1 (fr) * 1992-11-12 1994-05-26 Sheldon Goldstein Dispositif de mesures multiples de la coagulation et mode d'emploi
IL113010A0 (en) * 1994-03-31 1995-10-31 Pharmacia Ab Pharmaceutical formulation comprising factor VIII or factor ix with an activity of at least 200 IU/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration
DE4416166C2 (de) * 1994-05-06 1997-11-20 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen

Also Published As

Publication number Publication date
CA2156991A1 (fr) 1996-02-27
EP0700684A2 (fr) 1996-03-13
JP3859176B2 (ja) 2006-12-20
AU3025795A (en) 1996-04-04
JPH0859504A (ja) 1996-03-05
DE4430205A1 (de) 1996-02-29
KR960006938A (ko) 1996-03-22
EP0700684A3 (fr) 1997-01-08
IL115058A0 (en) 1995-12-08

Similar Documents

Publication Publication Date Title
ZA957139B (en) Compositions which are suitable for employment as antidotes to blood anticoagulants and their use
FI972387A (fi) Iholle levitettäviä parasitisidikoostumuksia
IL115039A (en) Spiroazabicyclic compounds, their preparation and pharmaceutical compositions containing them
IL114229A0 (en) Compositions for applying active substances to or through the skin
HU9602188D0 (en) Novel carbamate derivative and medicinal composition containing the same
IL115498A0 (en) Substituted alkyl 1-phenylalkyl-4-hydroxy-2-oxo- 1,8-naphthyridine-3-carboxylates their preparation and therapeutic compositions containing them
IL94910A0 (en) Biomedical adhesive compositions
HU9503250D0 (en) Pyridazinones and their use as fungicides and compositions containing them
IL110037A0 (en) Arylacetamides, their preparation, compositions containing them and their use as fungicides
PL332430A1 (en) Skin care compositions containing combinations of compounds capable to simulate the action of retinic acid onto skin
ZA9557B (en) Optionally substituted phenylimidazolidines their preparation process and intermediates their use as medicaments and the pharmaceutical compositions containing them
EP0768089A4 (fr) Composition favorisant la sante
ZA917429B (en) 2-phenylpyrimidines,processes for their preparation,compositions containing them,and their use as fungicides
GB8601452D0 (en) Polymerisable compositions
IL112291A0 (en) Alpha-pyrimidinyl acrylic acid derivatives, their preparation and fungicidal compositions containing them
EP0904073A4 (fr) Procedes et compositions zwitterioniques utilisees comme modificateurs de reponse biologique
GB9006201D0 (en) Skin composition
IL116015A0 (en) Iminooxymethyleneanilides thdir preparation and compositions containing them
ZA917428B (en) 4-anilinopyrimidines,processes for their preparation,compositions containing them,and their use as fungicides
EP0269568A3 (en) Polymerisable compositions
ZA954655B (en) Novel taxoids their preparation and the pharmaceutical compositions which contain them
ZA90437B (en) Substituted triazoles,their preparation and compositions,for use as fungicides
IL113916A0 (en) Carbamoylcarbohydrazides their preparation compositions containing them and their use
GB9018836D0 (en) Desensitising dental composition
ZA948137B (en) Novel taxoids their preparation and compositions which contain them